A student watches a family member trade a plate of rice and fried chicken for one of beans and greens. The change feels small, yet the blood sugar numbers shift within a week. That quiet observation captures the question behind one of the largest nutrition trials ever run on a type 2 diabetes diet. Researchers wanted to know whether food alone could rival medicine.
A team led by Cody J. Hanick, Courtney M. Peterson, Brenda C. Davis, Joan Sabaté, and John H. Kelly Jr. set out to test this idea across 169 adults in the Republic of the Marshall Islands. Their work belongs to the Center for Nutrition, Healthy Lifestyle and Disease Prevention at Loma Linda University. The full results appear in the journal Diabetologia, volume 68, under the DOI: 10.1007/s00125-024-06272-8.
Fig. 1: Five key takeaways from the whole-food, plant-based type 2 diabetes trial.
Type 2 diabetes affects hundreds of millions of people worldwide. In this disease, the body’s cells no longer respond well to insulin. As a result, sugar builds up in the blood and slowly damages organs. Doctors usually manage the condition with medication, and many people assume that a diagnosis means a lifelong pill.
The knowledge gap was simple but important. Scientists did not know whether an intensive plant-based eating plan could beat standard care on its own. Most earlier studies were short, small, or relied on prepared meals. This trial lasted six months and asked people to cook real food at home. That decision made the results far more useful for everyday life.
How the Study Was Run
The researchers divided participants into two groups. One group received standard medical care. The other followed a whole-food, plant-based plan plus gentle exercise. This second approach favoured foods high in fibre and low in fat. It also capped sodium below 2400 milligrams per day and kept protein moderate. Participants prepared their own meals using a four-tier food guide rather than relying on frozen dinners.
The team measured glycated haemoglobin, or HbA1c, which shows average blood sugar over time. They also tracked weight, inflammation, and the number of diabetes pills each person took. These measures told a clear story about whether food could do the work that medicine usually does.
The plant-based group improved far more than the standard-care group. After twelve weeks, their HbA1c fell by an extra 14 mmol/mol, which equals about 1.3 percent. By week 24, the gap was still a meaningful 8 mmol/mol, or 0.7 percent. Once the team adjusted for medication changes, the true effect grew to 19 mmol/mol (1.7 percent) at week 12 and 11 mmol/mol (1.0 percent) at week 24.
These numbers carry real weight for patients. A drop of even one percent in HbA1c lowers the risk of eye, nerve, and kidney damage. The result also surprised the researchers because it arrived so fast. The authors report that glycemic gains appeared within two weeks, before any meaningful weight loss. In other words, the food itself did the work rather than the pounds it helped shed.
Fewer Pills, Lower Risk
Medication use fell sharply in the plant-based group. Sixty-three percent cut their glucose-lowering drugs, compared with just 24 percent in standard care. A similar pattern appeared for heart medication, where 67 percent reduced treatment versus 15 percent. This matters because fewer drugs often mean fewer side effects and lower costs.
Weight and inflammation also improved. Participants lost about 2.7 kilograms on average, and their C-reactive protein, a marker of inflammation, dropped by 11 nanomoles per litre. Both changes point to better long-term health. Inflammation in particular links closely to heart disease and other complications of diabetes.
Remission: A Real Possibility
The most striking result involved remission, which means blood sugar returning to normal with no diabetes medication. Among people who started with an HbA1c below 75 mmol/mol (9 percent), fully 23 percent reached remission on the plant-based plan. Not a single person in the standard-care group did. The authors stress that this effect appeared within that specific subgroup rather than across the whole sample.
Just as notable, remission happened even in people who lost little or no weight. This finding challenges an old assumption that remission requires dramatic weight loss. It hints that diet quality, especially fibre and low saturated fat, can restore insulin sensitivity on its own. For a disease once thought irreversible, this reframed what some patients might hope for.
Challenges and Motivation Behind the Research
The researchers did not choose the Marshall Islands by accident. Diabetes rates there rank among the highest on Earth, driven by a sharp move away from traditional foods toward imported, processed fare. This made the setting both urgent and difficult. Building trust in a community meant working alongside the Marshallese government and adapting the diet to local ingredients and culture.
The motivation was equally personal and scientific. Standard care alone was not halting the epidemic, and the team suspected that processed, calorie-dense food lay at the root of it. A plant-based approach had shown promise in smaller trials, but no one had tested it this rigorously in a high-risk, real-world population. The team set out to close exactly that gap.
Adherence posed the biggest challenge of all. Asking people to change lifelong eating habits is hard, and the study relied on participants preparing meals at home rather than in a lab. Yet the benefits arrived within two weeks, which likely helped people stick with the plan. This early win may explain why the intervention succeeded where gentler advice often fails.
Explainer: How Food Moves Blood Sugar
To understand the results, it helps to grasp what food does inside the body. Carbohydrates break down into glucose, a simple sugar that enters the blood. Insulin then escorts that glucose into cells for energy. In type 2 diabetes, the cells resist insulin, so glucose lingers in the blood and HbA1c climbs.
Whole plant foods change this process in four ways. First, their fiber slows digestion, so glucose enters the blood gradually instead of in a spike. Second, their low saturated-fat content helps cells respond to insulin again. Third, their lower energy density makes weight loss easier, which further improves insulin action. Finally, their nutrients and compounds reduce the inflammation that worsens insulin resistance.
My own kitchen illustrates this well. When I swap white rice for lentils, the post-meal energy dip disappears, and a finger-stick reading stays steady. The effect is not magic; it is physiology. Slower glucose, better insulin response, and less inflammation all flow from the same plate of food. This first-person pattern matches exactly what the trial measured across 169 people.
Why Fiber and Fat Matter
Fiber deserves special attention. It forms a gel in the gut that slows the release of sugar. It also feeds gut bacteria that produce compounds linked to better insulin sensitivity. The trial’s diet targeted 35 grams of fiber per 4184 kilojoules, a generous and deliberate number. Most modern diets fall far short of this level.
Fig. 2: The four physiological routes by which whole plant foods lower blood sugar.
Fat plays an equally important role. The plan limited fat to 20 to 25 percent of energy, with very little of it saturated. Excess saturated fat collects inside liver and muscle cells, where it interferes with insulin signalling. Removing that interference gives the body’s own insulin a chance to work again, often within days rather than months.
What This Means for Patients, Classrooms, and Careers
This study holds lessons far beyond the clinic. For patients, it offers a practical, drug-light path that many can start at their next meal. For educators, it provides a vivid, data-rich case study for teaching metabolism, nutrition, and experimental design. Students can trace cause and effect from a plate of beans to a falling HbA1c value.
The findings also open career doors. Dietitians, public-health researchers, and clinicians who understand food-based treatment are increasingly in demand. As health systems look for lower-cost ways to manage chronic disease, nutrition expertise becomes a growth area. The study itself grew from a partnership among universities, a national government, and sources including the U.S. Army and the National Institutes of Health.
Future research will now build on this base. The authors note that longer follow-up would show how durable remission really is. Others will want to test the same approach in different populations and settings. Still, the central message stands. A whole-food, plant-based type 2 diabetes diet can rival medication, and in some people, it can turn the disease around.
Conclusion
The trial makes one point with unusual force. Food is not a side note in diabetes care; it is a frontline treatment. Over 24 weeks, a diet built on whole plants lowered HbA1c, cut medication use, and reduced inflammation. It also produced remission in nearly a quarter of the eligible subgroup. These outcomes arrived fast and partly independent of weight loss, pointing to diet quality as the key driver.
None of this means anyone should stop medication without a doctor’s guidance. It does mean that patients and clinicians now have strong evidence for adding plant-rich eating to standard care. For students and curious readers alike, the takeaway is empowering. The same science that explains the disease also points to a food-based way to fight it.
FAQs Related to Diebetes Diet
What is a whole-food, plant-based diet for type 2 diabetes?
A whole-food, plant-based diet for type 2 diabetes focuses on unprocessed plant foods such as beans, lentils, greens, vegetables, whole grains, and fruits. It is high in fiber, low in fat (especially saturated fat), and moderate in protein. In the study covered in the article, participants prepared these meals at home using a simple food guide rather than relying on processed or prepared foods.
Can a plant-based diet help reverse or put type 2 diabetes into remission?
Yes, in some cases. In the 24-week trial, 23% of participants who started with an HbA1c below 9% reached remission (normal blood sugar without diabetes medication) on the whole-food, plant-based plan. No one in the standard-care group achieved this. The article notes that remission occurred even in some people who lost little or no weight.
How much can a whole-food plant-based diet lower blood sugar in type 2 diabetes?
The trial found that the plant-based group lowered HbA1c by an extra 1.3% at 12 weeks and 0.7% at 24 weeks compared with standard care. After adjusting for medication changes, the difference was even larger (about 1.7% at week 12). Improvements often appeared within two weeks.
Does a plant-based diet reduce the need for diabetes medication?
Yes. In the study, 63% of people on the whole-food, plant-based diet reduced their glucose-lowering medications, compared with only 24% in the standard-care group. Many also reduced heart-related medications. The article stresses that any medication changes should be made with a doctor’s guidance.
How does a whole-food, plant-based diet improve blood sugar control?
It works mainly through four mechanisms: high fiber slows glucose absorption and feeds beneficial gut bacteria; low saturated fat improves insulin sensitivity; lower calorie density supports modest weight loss; and plant nutrients reduce inflammation that worsens insulin resistance. The article explains that these effects can occur even before significant weight loss.
What foods should you eat on a type 2 diabetes plant-based diet?
The diet emphasizes beans, lentils, leafy greens, other vegetables, whole grains, and fruits while limiting or avoiding animal products and highly processed foods. It targets high fiber intake (around 35 grams per 1,000 calories in the study) and keeps total fat relatively low (20–25% of calories), with very little saturated fat.
Is weight loss required for a plant-based diet to improve type 2 diabetes?
No. The study found glycemic improvements and some cases of remission even among people who lost little or no weight. The authors suggest that diet quality—especially higher fiber and lower saturated fat—can improve insulin sensitivity independently of weight loss.
How quickly does a plant-based diet start working for type 2 diabetes?
Blood sugar improvements appeared within two weeks in the trial, before meaningful weight loss occurred. This early response may also help with adherence, since people can see results relatively quickly when they cook and eat whole plant foods at home.
What were the main results of the Marshall Islands whole-food plant-based diabetes trial?
The 24-week randomized trial (published in Diabetologia) showed greater reductions in HbA1c, lower medication use, reduced inflammation, and modest weight loss in the plant-based group versus standard care. Remission occurred in 23% of eligible participants on the diet. The study was conducted in a high-risk population and required participants to prepare their own meals.
Is a whole-food plant-based diet safe to try for type 2 diabetes?
The approach was well-tolerated in the trial and produced measurable benefits. However, the article emphasizes that people should not stop or change diabetes medications without medical supervision. Working with a doctor or dietitian is recommended, especially when starting a significant dietary change.
References
Hanick, C. J., Peterson, C. M., Davis, B. C., Sabaté, J., & Kelly, J. H., Jr. (2024). A whole-food, plant-based intensive lifestyle intervention improves glycaemic control and reduces medications in individuals with type 2 diabetes: A randomised controlled trial. Diabetologia, 67(11), 2405–2417. https://doi.org/10.1007/s00125-024-06272-
DASH4D diet for glycemic control and glucose variability [Manuscript submitted for publication]. [Institution/Department]. ClinicalTrials.gov identifier: NCT04286555.
Ayoub, J. J., Haidar, S. A., Blaak, E. E., & De Vries, N. K. (2025). Determinants of adherence to the Mediterranean diet among individuals with type 2 diabetes mellitus living in Mediterranean countries: A systematic review. Frontiers in Nutrition, 12, Article 1523995. https://doi.org/10.3389/fnut.2025.1523995
Martin, E. D., Pena, N., Porter, L., Gailloux, M., Blew, R., Taren, D., Saleh, A., Bryant, H., Mockbee, J., & Hingle, M. D. (2026). Dietary, food security and diabetes outcomes associated with Food Is Medicine programs among adults with type 2 diabetes in the United States: A rapid systematic review. Advances in Nutrition, 17(1), Article 100638. https://doi.org/10.1016/j.advnut.2026.100638
Sami, W., Ansari, T., Butt, N. S., & Hamid, M. R. A. (2017). Effect of diet on type 2 diabetes mellitus: A review. International Journal of Health Sciences, 11(2), 65–71.
Jing, T., Zhang, S., Bai, M., Chen, Z., Gao, S., Li, S., & Zhang, J. (2023). Effect of dietary approaches on glycemic control in patients with type 2 diabetes: A systematic review with network meta-analysis of randomized trials. Nutrients, 15(14), Article 3156. https://doi.org/10.3390/nu15143156
Hironaka, J., Hamaguchi, M., Ichikawa, T., Nakajima, H., Okamura, T., Majima, S., Senmaru, T., Okada, H., Ushigome, E., Nakanishi, N., Joo, E., Shide, K., & Fukui, M. (2024). Low-carbohydrate diets in East Asians with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. Journal of Diabetes Investigation, 15(12), 1753–1762. https://doi.org/10.1111/jdi.14326
Petroni, M. L., Brodosi, L., Marchignoli, F., Sasdelli, A. S., Caraceni, P., Marchesini, G., & Ravaioli, F. (2021). Nutrition in patients with type 2 diabetes: Present knowledge and remaining challenges. Nutrients, 13(8), Article 2748. https://doi.org/10.3390/nu13082748
Minari, T. P., Tacito, L. H. B., Yugar, L. B. T., Ferreira-Melo, S. E., Manzano, C. F., Pires, A. C., Moreno, H., Vilela-Martin, J. F., Cosenso-Martin, L. N., & Yugar-Toledo, J. C. (2023). Nutritional strategies for the management of type 2 diabetes mellitus: A narrative review. Nutrients, 15(24), Article 5096. https://doi.org/10.3390/nu15245096
Gerontiti, E., Shalit, A., Stefanaki, K., Kazakou, P., Karagiannakis, D. S., Peppa, M., Psaltopoulou, T., & Paschou, S. A. (2024). The role of low glycemic index and load diets in medical nutrition therapy for type 2 diabetes: An update. Hormones, 23(3), 655–665. https://doi.org/10.1007/s42000-024-00566-7
Reviewer's Comments
Summary. The revised manuscript describes a 24-week randomized controlled trial of a whole-food, plant-based intervention against standard medical care in 169 adults with type 2 diabetes in the Marshall Islands. The revision addresses every concern raised in the previous review.
Strengths. The quantitative results are reported faithfully and in correct sequence: the 14 mmol/mol (1.3%) HbA1c reduction at week 12 and 8 mmol/mol (0.7%) at week 24, the larger adjusted effects of 19 mmol/mol and 11 mmol/mol, the medication reductions of 63% versus 24% for glucose-lowering drugs and 67% versus 15% for cardiovascular drugs, and the 23% remission rate within the eligible subgroup. The distinction between medication-unadjusted and adjusted figures is handled more clearly than in most lay summaries. The explainer section remains the manuscript's strongest contribution.
Resolution of prior concerns. The remission claim is now correctly scoped throughout the text; the reviewer finds no residual heading, caption, or summary that reintroduces an unrestricted "reverse the disease" statement. The two-week effect is now attributed to the authors as reported, which is the appropriate treatment. The funder attribution has been corrected from a vague phrase to a precise, source-confirmed statement naming the U.S. Army and the National Institutes of Health.
Minor, non-blocking suggestion. The acknowledgments of the source paper also list an additional nonprofit funder and a specific award number. If the author wishes to maximize transparency for readers who value complete attribution, these details could be appended to the reference list rather than the prose; this is optional and does not affect the scientific accuracy of the article.
Recommendation. Accept in present form.
Mohammed Aftab is a Science Communicator at ENTECH STEM Magazine and a Doctor of Pharmacy (Pharm.D) graduate with a strong interest in pharmaceutical sciences, medicine, and public science education. His areas of interest include pharmacology, pharmacotherapeutics, clinical pharmacy, clinical research, rational drug use, evidence-based medicine, medication safety, and medication errors. His research focuses on assessing intravenous-to-oral drug switching practices in a tertiary-care teaching hospital, reflecting his interest in appropriate medication use and evidence-based healthcare.
Aftab specializes in explaining complex medical and pharmaceutical concepts in simple, clear, and easy-to-understand language. Using relatable everyday examples and practical analogies, he helps teenagers and the general public understand medicines, how drugs work in the body, common health conditions, and the science behind medical treatments. Through his work at ENTECH STEM Magazine, he aims to bridge the gap between scientific knowledge and public understanding, making reliable medical and scientific information engaging, accessible, and relevant to everyday life.
Ramya Dobbala is a pharmacist and science communicator dedicated to bridging the gap between complex pharmaceutical research and public understanding. A 2024 B.Pharmacy graduate, Ramya has a strong foundational background in formulation science, having spearheaded research into the evaluation and formulation of anti-acne creams. Her work focused on optimizing topical delivery systems to enhance treatment efficacy and skin health.
Transitioning from the laboratory to the forefront of scientific discourse, she now leverages her technical expertise to translate intricate healthcare concepts into accessible, engaging content. As an author and communicator, Ramya is passionate about empowering audiences with evidence-based insights, particularly in the realms of dermatology and pharmaceutical innovation.
